Israeli medical device company GluSense grabs funding
Israel-based GluSense, a medical device company focused on treating diabetes, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
15 February 2017•3 mins read
Israel-based GluSense, a medical device company focused on treating diabetes, has secured an undisclosed amount of funding. The investor was JDRF T1D Fund.
